PUBLICATION REGISTRY

Go to research.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för fluvastatin sodium. Visa hela publikationsregistret

A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publications in the selection

9 hits

Bibliografisk träff 2012-10-04

Solid-state characterization and dissolution properties of Fluvastatin sodium salt hydrates.

Borgmann SH, Bernardi LS, Rauber GS, Oliveira PR, Campos CE, Monti G, Cuffini SL, Cardoso SG.

Pharm Dev Technol · journal article · DOI 10.3109/10837450.2012.727000

Bibliografisk träff 2010-01-08

Low-dosage statins reduce choroidal damage in hypercholesterolemic rabbits.

Rojas B, Ramírez AI, Salazar JJ, de Hoz R, Redondo A, Raposo R, Mendez T, Tejerina T, Triviño A, Ramírez JM.

Acta Ophthalmol · research support, non-u.s. gov't; journal article · DOI 10.1111/j.1755-3768.2009.01829.x

Bibliografisk träff 2002-01-12

Electrochemical study of fluvastatin sodium--analytical application to pharmaceutical dosage forms, human serum, and simulated gastric juice.

Ozkan SA, Uslu B.

Anal Bioanal Chem · journal article · DOI 10.1007/s00216-001-1223-5

Bibliografisk träff 2001-02-01

Antioxidative effect of fluvastatin, an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, on peroxidation of phospholipid liposomes.

Yamamoto A, Ichihara K, Hoshi K.

J Pharm Pharmacol · comparative study; journal article · DOI 10.1211/0022357011775244

Bibliografisk träff 2000-05-01

Fluvastatin, an HMG-CoA reductase inhibitor, protects LDL from oxidative modification in hypercholesterolemic rabbits.

Yasuhara M, Suzumura K, Tanaka K, Takahashi M, Aoki S, Odawara A, Narita H, Suzuki T.

Biol Pharm Bull · journal article · DOI 10.1248/bpb.23.570

Bibliografisk träff 1999-03-01

Protective effect of fluvastatin sodium (XU-62-320), a 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor, on oxidative modification of human low-density lipoprotein in vitro.

Suzumura K, Yasuhara M, Tanaka K, Suzuki T.

Biochem Pharmacol · comparative study; journal article · DOI 10.1016/s0006-2952(98)00341-4

Bibliografisk träff 1995-10-01

High dose of fluvastatin sodium (XU62-320), a new inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, lowers plasma cholesterol levels in homozygous Watanabe-heritable hyperlipidemic rabbits.

Kurokawa J, Hayashi K, Toyota Y, Shingu T, Shiomi M, Kajiyama G.

Biochim Biophys Acta · journal article · DOI 10.1016/0005-2760(95)00155-6

Bibliografisk träff 1993-07-01

Biotransformation of fluvastatin sodium in humans.

Dain JG, Fu E, Gorski J, Nicoletti J, Scallen TJ.

Drug Metab Dispos · journal article · DOI 10.1016/s0090-9556(25)07457-4

Bibliografisk träff 1993-04-01

Effect of fluvastatin sodium (XU62-320), a new inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, on the induction of low-density lipoprotein receptor in HepG2 cells.

Hayashi K, Kurokawa J, Nomura S, Kuga Y, Ohkura Y, Kajiyama G.

Biochim Biophys Acta · journal article · DOI 10.1016/0005-2760(93)90166-7